Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company MicroBio Group
DescriptionHCV NS5A protein inhibitor
Molecular Target HCV NS5A protein
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationHepatitis C virus (HCV)
Indication DetailsTreat chronic hepatitis C infection, in patients with genotypes 1b, 2a and 3a
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today